SANUWAVE Health Inc
OTC:SNWV

Watchlist Manager
SANUWAVE Health Inc Logo
SANUWAVE Health Inc
OTC:SNWV
Watchlist
Price: 32.695 USD -3.55% Market Closed
Market Cap: 280.5m USD

SANUWAVE Health Inc
Selling, General & Administrative

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

SANUWAVE Health Inc
Selling, General & Administrative Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Selling, General & Administrative CAGR 3Y CAGR 5Y CAGR 10Y
SANUWAVE Health Inc
OTC:SNWV
Selling, General & Administrative
-$23.7m
CAGR 3-Years
-8%
CAGR 5-Years
-10%
CAGR 10-Years
-25%
Boston Scientific Corp
NYSE:BSX
Selling, General & Administrative
-$6.7B
CAGR 3-Years
-14%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Stryker Corp
NYSE:SYK
Selling, General & Administrative
-$8.1B
CAGR 3-Years
-11%
CAGR 5-Years
-11%
CAGR 10-Years
-9%
Abbott Laboratories
NYSE:ABT
Selling, General & Administrative
-$12B
CAGR 3-Years
-2%
CAGR 5-Years
-5%
CAGR 10-Years
-6%
IDEXX Laboratories Inc
NASDAQ:IDXX
Selling, General & Administrative
-$1B
CAGR 3-Years
-6%
CAGR 5-Years
-7%
CAGR 10-Years
-8%
Intuitive Surgical Inc
NASDAQ:ISRG
Selling, General & Administrative
-$2.3B
CAGR 3-Years
-12%
CAGR 5-Years
-13%
CAGR 10-Years
-14%
No Stocks Found

SANUWAVE Health Inc
Glance View

Market Cap
280.4m USD
Industry
Health Care

SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. The company is headquartered in Suwanee, Georgia and currently employs 43 full-time employees. The company went IPO on 2008-11-07. The firm's is focused on regenerative medicine utilizing noninvasive, acoustic shock waves to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body’s normal healing processes and regeneration. The firm's lead regenerative product in the United States is the dermaPACE device, used for treating diabetic foot ulcers. The company intends to apply its Pulsed Acoustic Cellular Expression (PACE) technology in wound healing, orthopedic, plastic/cosmetic and cardiac conditions.

SNWV Intrinsic Value
33.26 USD
Undervaluation 2%
Intrinsic Value
Price

See Also

What is SANUWAVE Health Inc's Selling, General & Administrative?
Selling, General & Administrative
-23.7m USD

Based on the financial report for Sep 30, 2025, SANUWAVE Health Inc's Selling, General & Administrative amounts to -23.7m USD.

What is SANUWAVE Health Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-25%

Over the last year, the Selling, General & Administrative growth was -48%. The average annual Selling, General & Administrative growth rates for SANUWAVE Health Inc have been -8% over the past three years , -10% over the past five years , and -25% over the past ten years .

Back to Top